Julie Andrews, Director at RxSight, Inc. (RXST), sold 31,250 shares at $57.84 ($1.8M) on 2024-06-14, disclosed to the SEC on 2024-06-17.
Scheduled sale ($1.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.84 | 11,940 | $691K | 38.1% |
| 2 | $57.84 | 11,940 | $691K | 38.1% |
| 3 | $58.53 | 3,685 | $216K | 11.9% |
| 4 | $58.53 | 3,685 | $216K | 11.9% |
| Total | $58.00 avg | 31,250 | $1.8M | 100% |
| Filing → |
| OFIX | SELL | 2025-01-21 | $167K | — | Filing → |
| RXST | BUY | 2021-08-05 | $250K | — | Filing → |
| WMGI | SELL | 2020-08-19 | $33K | — | Filing → |